Skip to content

Radical Cystectomy, Nutrition and Convalescence

RADICAL CYSTECTOMY, NUTRITION AND CONVALESCENCE: CAN GOAL-DIRECTED POSTOPERATIVE NUTRITIONAL THERAPY REDUCE THE CONVALESCENCE PERIOD FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY (RC)?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02238886
Enrollment
36
Registered
2014-09-12
Start date
2012-05-31
Completion date
2013-12-31
Last updated
2014-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Cystectomy, Urinary Bladder Neoplasms

Keywords

Quality of Life, Enteral nutrition, Nutrition Therapy, Parenteral nutrition, total

Brief summary

The purpose of this study is to determine whether a goal directed nutritional intervention can reduce the convalescence period for patients undergoing radical cystectomy (RC). The aim is to examine the effect on quality of life of a standard nutritional strategy of resting the bowel till clear signs of bowel recovery and feeding orally after bowel recovery versus a goal-directed nutritional intervention combining oral intake and parenteral nutrition, in patients undergoing RC.

Detailed description

The study is a randomized controlled trial. Inclusion criteria: Bladder cancer, ability to give an informed consent. Exclusion criteria: Previous radiation therapy at the pelvic area, ureterocutaneostomy or robot-assisted surgery. The intervention aims to secure that 75% of the patient's total energy and protein needs are met during hospitalization. Primary outcome: Quality of Life, using the EORTC QLQ-C30 and BLM30 questionnaire. Secondary outcomes: Body-weight, Hand Grip strength, biochemical measures, length of hospital stay, time to bowel recovery. The follow-up period is 12 weeks. Statistical analysis is performed in collaboration with a statistician.

Interventions

DIETARY_SUPPLEMENTParenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bladder cancer * Ability to give an informed consent

Exclusion criteria

* Previous radiation therapy at the pelvic area * Ureterocutaneostomy * Robot-assisted surgery

Design outcomes

Primary

MeasureTime frameDescription
Health related quality of life (HRQoL) using the EORTC QLQ-C30 and BLM30 (one combined questionnaire)meassured pre-operatively + 6 and 12 weeks following surgeryChange from baseline HRQoL at 6 and 12 weeks following surgery

Secondary

MeasureTime frameDescription
Body weightpreoperatively, 6 and 12 weeks postopChange from baseline weight at 6 and 12 weeks following the date of surgery
hand grip strengthpre-operatively, 6 days and 6 weeks postopChange from baseline hand grip strength at 6 days and 6 weeks following the date of surgery
length of hospital stay12 week follow-up
Time to bowel recovery12 week follow-up

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026